📊 Score Breakdown
Offering Ability
40
Cash Runway
0
Float Risk
65
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
7%
📉 Score Deterioration
15%
• Score climbed 5 points (worsening)
💹 Market Data
Market Cap$310.45M
Shares Outstanding27.18M
Float9.91M
Cash$97.02M
Debt$17.25M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 0.6% shares (2025Q4 vs prior)
56 institutional holders · 4.69M shares
#1
ORBIMED ADVISORS LLC
1.25M shares
#2
JANUS HENDERSON GROUP PLC
1.14M shares
#3
BlackRock, Inc.
427.5K shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest649.3K
Days to Cover3.9
% of Float6.5%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Dec 31, 2025
xbrl
XBRL WARRANT
Dec 31, 2025
4
INSIDER TRANSACTION
Mar 04, 2026
4
INSIDER TRANSACTION
Jan 30, 2026
4
INSIDER TRANSACTION
Jan 30, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for CARL
📊 CARL FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 CARL Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.